Reducing anticipated non-suicidal self-injury by improving body esteem in individuals with weight suppression: A proof of concept study.
Reducing anticipated non-suicidal self-injury by improving body esteem in individuals with weight suppression: A proof of concept study.
复制标题
通过改善体重抑制个体的身体自尊来减少预期的非自杀性自伤：概念验证研究。
DOI：
10.1002/eat.23011
复制
发表时间：
2019
期刊：
影响因子：
--
通讯作者：
Keel,PamelaK
中科院分区：
文献类型：
--
作者：
Kennedy,GraceA;JeanForney,Katherine;Pinner,Dennis;Martinez,KimberlyM;Buchman-Schmitt,JenniferM;Keel,PamelaK
研究表明，体重抑制（WS）与非自杀性自伤（NSSI）有关，而对瘦和抑郁的追求可能解释了这种关联。我们进行了一项概念验证研究，采用随机对照试验设计，以确定是否提高身体自尊和减少抑郁症状减少了WS.MethodWeight抑制参与者（N= 60）谁从事NSSI的个人从社区招募，并随机分配到一个在线干预或控制条件。在线干预从最初旨在减少女性瘦理想内化的认知失调干预调整为减少两性不健康身体理想内化的干预。在干预前和干预后，或在基线和2周随访时对参与者的体重/形状问题、抑郁症状和NSSI进行评估。结果与对照组相比，治疗条件下的参与者报告未来NSSI的可能性降低更大[Cohen d（95%CI）=-0.38（−0.90-0.15）]，重量/形状问题[−1.19（-1.75至-0.62）]、抑郁症状[-1.00（-1.56至-0.45）]，和外观的显著改善[1.27（0.70-1.84）]和体重自尊[1.38（0.80-1.96）]。讨论未来的工作可以在一个更大的试验中测试这种干预措施与积极的替代治疗条件。
ObjectiveResearch suggests that weight suppression (WS) is linked to non‐suicidal self‐injury (NSSI) and that drive for thinness and depression may explain this association. We conducted a proof‐of‐concept study using a randomized control trial design to determine if improving body esteem and reducing depressive symptoms reduced NSSI in individuals with WS.MethodWeight suppressed participants (N= 60) who engaged in NSSI were recruited from the community and randomly assigned to an on‐line intervention or control condition. The on‐line intervention was adapted from a cognitive‐dissonance intervention originally designed to reduce thin‐ideal internalization in females to an intervention to reduce internalization of unhealthy body ideals in both genders. Participants' weight/shape concerns, depressive symptoms, and NSSI were assessed at pre‐ and post‐intervention, or at baseline and 2‐week follow‐up for controls.ResultsCompared to controls, participants in the treatment condition reported greater decreases in likelihood of future NSSI [Cohen's d (95% CI) = −0.38 (−0.90–0.15)], weight/shape concerns [−1.19 (−1.75 to −0.62)], depressive symptoms [−1.00 (−1.56 to −0.45)], and significant improvements in appearance [1.27 (0.70–1.84)] and weight esteem [1.38 (0.80–1.96)].DiscussionFuture work could test this intervention in a larger trial with an active alternative treatment condition.